Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Reviews of Infectious Diseases|July 1, 1990
Overview of phase I trials of 2',3'-dideoxyinosine (ddI) conducted on adult patientsM Rozencweig, C McLaren, M Beltangady, et al.
Seminars in Oncology|June 1, 1995
Paclitaxel plus carboplatin in the treatment of ovarian cancerW ten Bokkel Huinink, C Veenhof, T Helmerhorst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1984
Etoposide (VP-16-213) in malignant brain tumors: a phase II studyU Tirelli, M D'Incalci, R Canetta, et al.
Seminars in Oncology|February 1, 1997
Carboplatin and paclitaxel in patients with advanced ovarian cancer: a dose-finding studyW ten Bokkel Huinink, C Veenhof, M Huizing, et al.
Cancer Research|November 1, 1992
Phase II preclinical drug screening in human tumor xenografts: a first European multicenter collaborative studyE Boven, B Winograd, D P Berger, et al.
Seminars in Oncology|December 1, 1992
Drug discovery and development in the pharmaceutical industryL P Schacter, C Anderson, R M Canetta, et al.
British Journal of Cancer|October 1, 1992
Growth, morphology and chemosensitivity studies on postconfluent cells cultured in 'V'-bottomed microtiter platesP E Pizao, D M Lyaruu, G J Peters, et al.
Journal of the National Cancer Institute|August 21, 1991
Phase I and clinical pharmacological evaluation of aphidicolin glycinateC Sessa, M Zucchetti, E Davoli, et al.
Anti-Cancer Drugs|December 10, 1999
Phase I and pharmacologic study of BMS-181174 given as a 6 h infusion every 4 weeks to patients with advanced solid tumorsA S Planting, J H Schellens, M E van der Burg, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Phase II study of carboplatin in recurrent ovarian cancer: severe hematologic toxicity in previously treated patientsN Colombo, J L Speyer, M Green, et al.
Pageof 7